Biotech company in phase III that you've probably never heard of...isn't that always the way. Apebetalone is the compound, company seeking to prove that it reduces Major Adverse Cardiac Events in patients with Diabetes Mellitus (aka full blown insulin dependent diabetes).
I think its a good candidate for a momo play....and for those willing to do the DD it might represent a good LT play too, although its obviously risky...if the phase III trial succeeds or they get bought out....KaBaM!!!
But phase III trials don't always succeed, so the risks are very real.
Here's a primer written before the golden cross set up that should come this week imo:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.